Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Kim, Aeyung ^a   Im, Minju ^a   Yim, Nam Hui ^a   Ma, Jin Yeul ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; DRUG SCREENING; EUPATORIUM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; METABOLISM; MOUSE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; RAT; SECONDARY; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AORTA; CELL MOVEMENT; CELL PROLIFERATION; EUPATORIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUNG NEOPLASMS; MAP KINASE KINASE 4; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLANT EXTRACTS; RATS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR STEM CELL ASSAY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84931282900     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06994     Document Type: Article

References (43)

1. Kumar, S. & Weaver, V. M. Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev 28, 113-127 (2009).
2. Patel, L. R., Camacho, D. F., Shiozawa, Y., Pienta, K. J. & Taichman, R. S. Mechanisms of cancer cell metastasis to the bone: a multistep process. Future Oncol 7, 1285-1297 (2011).
3. Westermarck, J. & Kahari, V. M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13, 781-792 (1999).
4. Rundhaug, J. E. Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin Cancer Res 9, 551-554 (2003).
5. Deryugina, E. I. & Quigley, J. P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25, 9-34 (2006).
6. Mira, E. et al. Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J Cell Sci 117, 1847-1857 (2004).
7. Zheng, H. et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26, 3579-3583 (2006).
8. Gondi, C. S. et al. Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biol 1, 165-176 (2004).
9. Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29, 15-18 (2002).
10. Kerbel, R. & Folkman, J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2, 727-739 (2002).
11. Izawa, J. I. & Dinney, C. P. The role of angiogenesis in prostate and other urologic cancers: a review. CMAJ 164, 662-670 (2001).
12. Folkman, J. & Klagsbrun, M. Angiogenic factors. Science 235, 442-447 (1987).
13. Bicknell, R. Vascular targeting and the inhibition of angiogenesis. Ann Oncol 5 Suppl 4, 45-50 (1994).
14. Gupta, M. K. & Qin, R. Y. Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 9, 1144-1155 (2003).
15. Appelmann, I., Liersch, R., Kessler, T., Mesters, R. M. & Berdel, W. E. Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy. Recent Results Cancer Res 180, 51-81 (2010).
16. Hui, Y. F. & Ignoffo, R. J. Angiogenesis inhibitors. A promising role in cancer therapy. Cancer Pract 6, 60-62 (1998).
17. Papetti, M. & Herman, I. M. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282, 947-970 (2002).
18. Ushiki, J. H. et al. Medicinal plants for suppressing soil-borne plant diseases. Soil Sci Plant Nutri 42, 423-426 (1996).
19. Chen, Y. F. et al. Relationship between antioxidant and antiglycation ability of saponins, polyphenols, and polysaccharides in Chinese herbal medicines used to treat diabetes. J Med Plants Res 5, 2322-2331 (2011).
20. Jiang, J. K. L. et al. Terpenoids from Eupatorium fortunei TURCZ. Helvetica chimica acta 89, 558-566 (2006).
21. Kim, Y. N., Koo, K. H., Sung, J. Y., Yun, U. J. & Kim, H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol 2012, Article ID 306879, 11 pages (2012).
22. Kim, A., Im, M., Yim, N. H., Jung, Y. P. &Ma, J. Y. Aqueous extract of Bambusae Caulis in Taeniam inhibits PMA-induced tumor cell invasion and pulmonary metastasis: suppression of NF-kappaB activation through ROS signaling. PLoS One 8, e78061 (2013).
23. Kim, A. et al. Suppression of the invasive potential of highly malignant tumor cells by KIOM-C, a novel herbal medicine, via inhibition of NF-kappaB activation and MMP-9 expression. Oncol Rep 31, 287-297 (2014).
24. Roomi, M. W., Monterrey, J. C., Kalinovsky, T., Rath, M. & Niedzwiecki, A. Patterns of MMP-2 and MMP-9 expression in human cancer cell lines. Oncol Rep 21, 1323-1333 (2009).
25. Choi, J. H. et al. Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NFkappaB- dependent MMP-9 expression. Food Chem Toxicol 48, 564-571 (2010).
26. Hwang, Y. P. et al. Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha/Raf/MAPKs and NF-kappaB/AP- 1-dependent mechanisms. Biochem Pharmacol 79, 1714-1726 (2010).
27. Reddy, K. B., Nabha, S. M. & Atanaskova, N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22, 395-403 (2003).
28. Yeh, C. B. et al. Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity. PLoS One 7, e31055 (2012).
29. Zhao, K. et al. Wogonin suppresses melanoma cell b16-f10 invasion and migration by inhibiting ras-medicated pathways. PLoS One 9, e106458 (2014).
30. Kim, A. et al. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis 30, 927-936 (2009).
31. Risau, W. Mechanisms of angiogenesis. Nature 386, 671-674 (1997).
32. Jang, Y. J., Kim, D. S. & Jeon, O. H. Saxatilin suppresses tumor-induced angiogenesis by regulating VEGF expression in NCI-H460 human lung cancer cells. J Biochem Mol Biol 40, 439-443 (2007).
33. Ye, J. & Yuan, L. Inhibition of p38 MAPK reduces tumor conditioned mediuminduced angiogenesis in co-cultured human umbilical vein endothelial cells and fibroblasts. Biosci Biotechnol Biochem 71, 1162-1169 (2007).
34. Grant, D. S. et al.Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 21, 4765-4777 (2002).
35. Fang, J. et al. Apigenin inhibits tumor angiogenesis through decreasing HIF- 1alpha and VEGF expression. Carcinogenesis 28, 858-864 (2007).
36. Staton, C. A. et al. Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol 85, 233-248 (2004).
37. Goodwin, A. M. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res 74, 172-183 (2007).
38. Hirota, K. & Semenza, G. L. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59, 15-26 (2006).
39. Qin, L. X. & Tang, Z. Y. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 8, 385-392 (2002).
40. Gan, R. Y. et al. Screening of natural antioxidants from traditional Chinese medicinal plants associated with treatment of rheumatic disease. Molecules 15, 5988-5997 (2010).
41. Fu, P. P. Y., Y, C., Xia, Q., Chou, M. C., Cui, Y. Y.& Lin, G. Pyrrolizidine alkaloidstumorigenic compounds in Chinese herbal medicines and dietary supplements. J Food Drug Anal 10, 198-211 (2002).
42. Ito, Y., Iwamoto, Y., Tanaka, K., Okuyama, K. & Sugioka, Y. A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo. Int J Cancer 67, 148-152 (1996).
43. Kim, A., Im,M., Yim, N. H., Kim, T.&Ma, J. Y. A novel herbalmedicine, KIOM-C, induces autophagic and apoptotic cell deathmediated by activation of JNK and reactive oxygen species in HT1080 human fibrosarcoma cells. PLoS One 9, e98703 (2014).